Accuray (ARAY) Assets Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.58% |
| Dec 31, 2025 | 21.02% |
| Sep 30, 2025 | 70.49% |
| Jun 30, 2025 | 72.29% |
| Mar 31, 2025 | 26.34% |
| Dec 31, 2024 | 23.48% |
| Sep 30, 2024 | 23.70% |
| Jun 30, 2024 | 37.79% |
| Mar 31, 2024 | 33.97% |
| Dec 31, 2023 | 42.03% |
| Sep 30, 2023 | 37.08% |
| Jun 30, 2023 | 30.74% |
| Mar 31, 2023 | 46.84% |
| Dec 31, 2022 | -39.65% |
| Sep 30, 2022 | -41.64% |
| Jun 30, 2022 | -40.58% |
| Mar 31, 2022 | -38.71% |
| Dec 31, 2021 | -39.74% |
| Sep 30, 2021 | -39.45% |
| Jun 30, 2021 | -47.59% |
| Mar 31, 2021 | -50.22% |
| Dec 31, 2020 | -53.23% |
| Sep 30, 2020 | -52.60% |
| Jun 30, 2020 | -53.60% |
| Mar 31, 2020 | -57.10% |
| Dec 31, 2019 | 4.92% |
| Sep 30, 2019 | 3.13% |
| Jun 30, 2019 | -2.24% |
| Mar 31, 2019 | -6.07% |
| Dec 31, 2018 | -6.57% |
| Sep 30, 2018 | -7.19% |
| Jun 30, 2018 | -6.73% |
| Mar 31, 2018 | -5.82% |
| Dec 31, 2017 | -3.98% |
| Sep 30, 2017 | -5.01% |
| Jun 30, 2017 | -6.37% |
| Mar 31, 2017 | -5.32% |
| Dec 31, 2016 | -5.06% |
| Sep 30, 2016 | -3.69% |
| Jun 30, 2016 | -0.49% |
| Mar 31, 2016 | -0.48% |
| Dec 31, 2015 | 4.43% |
| Sep 30, 2015 | 1.78% |
| Jun 30, 2015 | -0.45% |
| Mar 31, 2015 | -2.01% |
| Dec 31, 2014 | -1.69% |
| Sep 30, 2014 | -2.77% |
| Jun 30, 2014 | 2.80% |